Axcynsis Therapeutics

Singapore, Singapore · Founded 2022 · Privately Held (backing)

Developer of antibody-drug conjugate therapies designed for treating cancer. Axcynsis Therapeutics is based in Singapore, Singapore and was founded in 2022. Its last known valuation is $36.1 million. It has raised $21 million.

Last price · $/share

—

Implied valuation

$36.1M

Total raised

$21.0M

Last round

—

How much has Axcynsis Therapeutics raised?

$21.0Macross 0 recorded rounds

Free account

More of Axcynsis Therapeutics with a free account

·Watch Axcynsis Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Axcynsis Therapeutics investors

2 investors are on record for Axcynsis Therapeutics, including Hapi Investment Management and TIBS - Trinity funds.

For fundraisers

Raising for a company like Axcynsis Therapeutics?

2 investors have backed Axcynsis Therapeutics.

See all 2 investors →

Frequently asked about Axcynsis Therapeutics

How much has Axcynsis Therapeutics raised?: Axcynsis Therapeutics has raised $21.0M in total across 0 recorded funding rounds.